Magnera Corporation (MAGN)
NYSE: MAGN · Real-Time Price · USD
9.94
-0.63 (-5.96%)
May 15, 2026, 4:00 PM EDT - Market closed

Magnera Earnings Call Transcripts

Fiscal Year 2026

  • Adjusted EBITDA was $90 million, with strong free cash flow enabling $36 million in debt repayment. Weather disruptions and inflationary pressures impacted results, but guidance for full-year EBITDA and free cash flow remains unchanged, with recovery expected in Q4.

  • Magnera, formed by the merger of Berry Global's HHS division and Glatfelter, has completed integration and is focused on innovation, operational optimization, and debt reduction. The company leads in nonwovens, targets $395 million EBITDA in 2026, and manages input costs through contract mechanisms.

  • Magnera, formed from a 2024 merger, is a global leader in specialty nonwovens with a balanced revenue mix and strong innovation focus. 2026 guidance targets EBITDA growth and debt reduction, with key growth in wipes, adult incontinence, and infrastructure. Management remains confident in long-term value creation.

  • AGM 2026

    The meeting covered director elections, auditor ratification, and executive compensation approval, with all proposals passing by majority vote. No shareholder questions were submitted, and final voting results will be filed with the SEC.

  • Q1 results met expectations with $792M in sales and $93M Adjusted EBITDA, as synergy realization and Project Core drove performance despite regional headwinds. 2026 guidance targets 9% Adjusted EBITDA growth, flat volumes, and $100M in free cash flow, with strong cash generation supporting debt reduction.

Fiscal Year 2025

Powered by